The Diabetes Control and Complications Trial (DCCT) and its long-term follow-up, the Epidemiology of Diabetes Interventions and Complications (EDIC) study, provide robust evidence that intensive insulin therapy improves glycemic control and reduces cardiovascular events in individuals with type 1 diabetes. The gene discussed is INS; the disease is diabetes mellitus.